-
EP2878307
European procedure
Extract from the Register of European Patents
EP About this file: EP2878307
| EP2878307 - Immunogenic composition [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 03.07.2020 Database last updated on 14.11.2024 | |
| Former | The patent has been granted Status updated on 21.06.2019 | ||
| Former | Grant of patent is intended Status updated on 22.01.2019 | ||
| Former | Examination is in progress Status updated on 20.03.2017 | Most recent event Tooltip | 03.06.2022 | Lapse of the patent in a contracting state New state(s): CY | published on 06.07.2022 [2022/27] | Applicant(s) | For all designated states GlaxoSmithKline Biologicals S.A. Rue de l'Institut, 89 1330 Rixensart / BE | [2019/30] |
| Former [2015/23] | For all designated states GlaxoSmithKline Biologicals S.A. rue de l'Institut, 89 1330 Rixensart / BE | Inventor(s) | 01 /
Biemans, Ralph Leon GlaxoSmithKline Biologicals s.a. rue de l'Institut 89 1330 Rixensart / BE | 02 /
Boutriau, Dominique GlaxoSmithKline Biologicals s.a. rue de l'Institut 89 1330 Rixensart / BE | 03 /
Capiau, Carine GlaxoSmithKline Biologicals s.a. rue de l'Institut 89 1330 Rixensart / BE | 04 /
Denoel, Philippe GlaxoSmithKline Biologicals s.a. rue de l'Institut 89 1330 Rixensart / BE | 05 /
Duvivier, Pierre GlaxoSmithKline Biologicals s.a. rue de l'Institut 89 1330 Rixensart / BE | 06 /
Poolman, Jan GlaxoSmithKline Biologicals s.a. rue de l'Institut 89 1330 Rixensart / BE | [2015/23] | Representative(s) | J A Kemp LLP 80 Turnmill Street London EC1M 5QU / GB | [N/P] |
| Former [2019/30] | J A Kemp 14 South Square Gray's Inn London WC1R 5JJ / GB | ||
| Former [2015/23] | Johnston, Caroline Louise GlaxoSmithKline Global Patents (CN925.1) 980 Great West Road Brentford, Middlesex TW8 9GS / GB | Application number, filing date | 14198052.4 | 23.06.2006 | [2015/23] | Priority number, date | GB20050013069 | 27.06.2005 Original published format: GB 0513069 | GB20050013071 | 27.06.2005 Original published format: GB 0513071 | GB20050015556 | 28.07.2005 Original published format: GB 0515556 | GB20050024204 | 28.11.2005 Original published format: GB 0524204 | GB20050026041 | 21.12.2005 Original published format: GB 0526041 | GB20050026040 | 21.12.2005 Original published format: GB 0526040 | [2015/23] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2878307 | Date: | 03.06.2015 | Language: | EN | [2015/23] | Type: | B1 Patent specification | No.: | EP2878307 | Date: | 24.07.2019 | Language: | EN | [2019/30] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 04.05.2015 | Classification | IPC: | A61K39/095, A61K39/102, A61K39/116, A61P31/04 | [2015/23] | CPC: |
A61K39/385 (EP,NO,US);
A61K39/0017 (EP,NO,US);
A61K39/095 (EP,KR,NO,US);
A61K39/0018 (EP,NO,US);
A61K39/05 (NO,US);
A61K39/08 (NO,US);
A61K39/092 (NO,US);
A61K39/099 (NO,US);
A61K39/102 (EP,KR,NO,US);
A61K39/116 (KR,NO,US);
A61K39/12 (NO,US);
A61K39/145 (NO,US);
A61K39/292 (NO,US);
A61P11/04 (EP,NO);
A61P11/14 (EP);
A61P31/00 (EP,NO);
A61P31/04 (EP,NO);
A61P31/12 (EP,NO);
A61P31/20 (EP);
A61P37/00 (EP,NO);
A61P37/04 (EP,NO);
A61P43/00 (EP);
C07H3/00 (EP,US);
C12N7/00 (US);
A61K2039/545 (EP,US);
A61K2039/55 (US);
A61K2039/575 (US);
A61K2039/6037 (EP,NO,US);
A61K2039/62 (EP,NO,US);
A61K2039/627 (EP,NO,US);
A61K2039/70 (EP,NO,US);
C12N2730/10134 (EP,NO,US);
C12N2760/16234 (NO,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2015/23] | Extension states | HR | 17.02.2015 | Title | German: | Immunogene Zusammensetzung | [2015/23] | English: | Immunogenic composition | [2015/23] | French: | Composition immunogène | [2015/23] | Examination procedure | 15.12.2014 | Examination requested [2015/23] | 30.11.2015 | Amendment by applicant (claims and/or description) | 17.03.2017 | Despatch of a communication from the examining division (Time limit: M06) | 11.09.2017 | Reply to a communication from the examining division | 04.12.2018 | Date of oral proceedings | 15.01.2019 | Minutes of oral proceedings despatched | 23.01.2019 | Communication of intention to grant the patent | 28.05.2019 | Fee for grant paid | 28.05.2019 | Fee for publishing/printing paid | 28.05.2019 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP06754610.1 / EP1896064 | Opposition(s) | 03.06.2020 | No opposition filed within time limit [2020/32] | Fees paid | Renewal fee | 15.12.2014 | Renewal fee patent year 03 | 15.12.2014 | Renewal fee patent year 04 | 15.12.2014 | Renewal fee patent year 05 | 15.12.2014 | Renewal fee patent year 06 | 15.12.2014 | Renewal fee patent year 07 | 15.12.2014 | Renewal fee patent year 08 | 15.12.2014 | Renewal fee patent year 09 | 05.06.2015 | Renewal fee patent year 10 | 31.03.2016 | Renewal fee patent year 11 | 08.06.2017 | Renewal fee patent year 12 | 08.06.2018 | Renewal fee patent year 13 | 10.06.2019 | Renewal fee patent year 14 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | CY | 24.07.2019 | EE | 24.07.2019 | LT | 24.07.2019 | LV | 24.07.2019 | MC | 24.07.2019 | IS | 24.11.2019 | [2022/27] |
| Former [2021/12] | EE | 24.07.2019 | |
| LT | 24.07.2019 | ||
| LV | 24.07.2019 | ||
| MC | 24.07.2019 | ||
| IS | 24.11.2019 | ||
| Former [2020/36] | EE | 24.07.2019 | |
| LT | 24.07.2019 | ||
| LV | 24.07.2019 | ||
| IS | 24.11.2019 | ||
| Former [2020/24] | EE | 24.07.2019 | |
| LT | 24.07.2019 | ||
| LV | 24.07.2019 | ||
| IS | 24.02.2020 | ||
| Former [2020/22] | EE | 24.07.2019 | |
| LT | 24.07.2019 | ||
| LV | 24.07.2019 | ||
| IS | 24.11.2019 | ||
| Former [2020/13] | LT | 24.07.2019 | |
| LV | 24.07.2019 | ||
| IS | 24.11.2019 | ||
| Former [2020/08] | LT | 24.07.2019 | Documents cited: | Search | [I]WO02058737 (AVENTIS PASTEUR [US], et al); | [I]WO03007985 (CHIRON SPA [IT], et al); | [I]WO03094834 (UNIV LEIDEN [NL], et al); | [I]WO2004011027 (BAXTER INT [US], et al); | [I]WO2004067030 (CHIRON SRL [IT], et al); | [I]WO2004103400 (AVENTIS PASTEUR INC [US], et al); | [I]WO2005032583 (CHIRON SRL [IT], et al); | by applicant | US4057685 | US4235877 | US4365170 | US4459286 | EP0161188 | EP0208375 | US4673574 | US4709017 | EP0301992 | US4808700 | EP0372501 | EP0378881 | US4950740 | WO9101146 | EP0427347 | EP0471177 | EP0477508 | WO9315760 | WO9317712 | WO9403208 | EP0594610 | WO9508348 | WO9629094 | WO9842721 | US5843711 | WO9858668 | US5917017 | WO0010599 | WO0056360 | WO0061761 | WO0109350 | WO0172337 | WO02058737 | US6455673 | WO02091998 | WO2004014417 | WO2004014418 | WO2004014419 | WO2004083251 |